Home Nucleus Medical Devices Global Medication Assisted Therapy (MAT) Market to 2032

Global Medication Assisted Therapy (MAT) Market to 2032

Overview

The Global Medication Assisted Therapy (MAT) Market is expected to reach a 21,603.51 by 2032 and is projected to grow at a CAGR of 9.14% from 2025 to 2032.

Revenue, 2024 ()
10,559.91
Forecast, 2032 ()
21,603.51
CAGR, 2024 - 2032
9.14%
Report Coverage
Global

Global Medication Assisted Therapy (MAT) Market 2018-2032

Global Medication Assisted Therapy (MAT) Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 10,559.91
  • Projected Market Size (2032): 21,603.51
  • CAGR (2025-2032): 9.14%

Key Findings of Global Medication Assisted Therapy (MAT) Market

  • The Global Medication Assisted Therapy (MAT) Market was valued at 21,603.51 in 2024.
  • The Global Medication Assisted Therapy (MAT) Market is likely to grow at a CAGR of 9.14% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Adults in Population Type Segment accounted for the largest share of the market with a revenue of 10,006.00
  • The fastest growing segment Buprenorphine and Naloxone in Products Segment grew Fastest with a CAGR of 10.72% during the forecast period from 2024 to 2032.

Global Medication Assisted Therapy (MAT) Market Scope

Global Medication Assisted Therapy (MAT) Market Segmentation & Scope
Products
  • Acamprosate
  • Disulfarm
  • Naloxone
  • Metadone
  • Buprenorphine
  • Naltrexone
  • Buprenorphine and Naloxone
Drug Type
  • Branded
  • Generics
Dosage Form
  • Extented Release
  • Immediate Release
Route of Administration
  • Others
  • Parenteral
  • Oral
Type
  • Therapy
  • Medication
Population Type
  • Teenage
  • Adults
End User
  • Others
  • Homecare
  • Speciality Centers
  • Hospitals
  • Rehabilitation Clinics
Distribution Channel
  • Others
  • Online Pharmacy
  • Retail Pharmacy
  • Direct Tender
  • Hospital Pharmacy

Global Medication Assisted Therapy (MAT) Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in
Market Value in 2024 10,559.91
Market Value in 2032 21,603.51
CAGR (2025-2032) 9.14%
Historic Data 2016-2023
Market Segments Covered Products,Drug Type,Dosage Form,Route of Administration,Type,Population Type,End User,Distribution Channel

Regional Insights:

  • Leading Market (2024-2032): Global, leading in terms of revenue 10,559.91 in 2024
    • Key Country: U.S., leading in terms of revenue with value of 4,830.99 in 2024.

Segments and Scope

  • Global Medication Assisted Therapy (MAT) Market to 2032, By Products
    • Buprenorphine and Naloxone is the largest segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 1,581.36 in the year 2024.
    • Buprenorphine and Naloxone is the Fastest growing segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 10.72 % in forecast period 2025-2032.
  • Global Medication Assisted Therapy (MAT) Market to 2032, By Drug Type
    • Generics is the largest segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 4,161.93 in the year 2024.
    • Generics is the Fastest growing segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 9.94 % in forecast period 2025-2032.
  • Global Medication Assisted Therapy (MAT) Market to 2032, By Dosage Form
    • Immediate Release is the largest segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 3,504.57 in the year 2024.
    • Immediate Release is the Fastest growing segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 9.95 % in forecast period 2025-2032.
  • Global Medication Assisted Therapy (MAT) Market to 2032, By Route of Administration
    • Oral is the largest segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 2,917.66 in the year 2024.
    • Oral is the Fastest growing segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 10.15 % in forecast period 2025-2032.
  • Global Medication Assisted Therapy (MAT) Market to 2032, By Type
    • Medication is the largest segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 5,802.01 in the year 2024.
    • Medication is the Fastest growing segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 9.59 % in forecast period 2025-2032.
  • Global Medication Assisted Therapy (MAT) Market to 2032, By Population Type
    • Adults is the largest segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 10,006.00 in the year 2024.
    • Adults is the Fastest growing segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 9.20 % in forecast period 2025-2032.
  • Global Medication Assisted Therapy (MAT) Market to 2032, By End User
    • Rehabilitation Clinics is the largest segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 4,280.04 in the year 2024.
    • Rehabilitation Clinics is the Fastest growing segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 10.08 % in forecast period 2025-2032.
  • Global Medication Assisted Therapy (MAT) Market to 2032, By Distribution Channel
    • Hospital Pharmacy is the largest segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 3,002.70 in the year 2024.
    • Hospital Pharmacy is the Fastest growing segment in Global Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 10.22 % in forecast period 2025-2032.

Global Medication Assisted Therapy (MAT) Market Company Share Analysis

 
Company Name Company Share Analysis
Viatris Inc.
Indivior PLC
Mallinckrodt
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Global Medication Assisted Therapy (MAT) Market Company Share Analysis

Global Medication Assisted Therapy (MAT) Market Geographical Sales Distribution, 2018-2032

Global Medication Assisted Therapy (MAT) Market Geographical Sales Distribution, 2018-2032

Global Medication Assisted Therapy (MAT) Market Company Profiling

Global Medication Assisted Therapy (MAT) Market Company Profiling

Industry Related Reports

Global Cleanroom Technology Market
Global Cochlear Implant Market
Global Chronic Diseases Management Market
Global Hospital Furniture Market
Global Human Fibrin Glue Market
Global Healthcare 3D Printing Market
Global Hydrocephalus Market
Global Intraoperative Radiation Therapy Market
Global Surgical Power Tools Market
Global Inorganic Scintillators Market
Frequently Asked Questions
The Global Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Products,Drug Type,Dosage Form,Route of Administration,Type,Population Type,End User,Distribution Channel.
Global Medication Assisted Therapy (MAT) Market was valued at USD 10,559.91(Revenue in ) in 2020.
Global Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 9.14% during the forecast period of 2024 to 2032.
The Adults segment is expected to dominate the Global Medication Assisted Therapy (MAT) Market, holding a largest market share of 10,006.00 in 2024

Coming Soon....

Global Medication Assisted Therapy (MAT) Market Scope

Global Medication Assisted Therapy (MAT) Market Segmentation & Scope
Products
  • Acamprosate
  • Disulfarm
  • Naloxone
  • Metadone
  • Buprenorphine
  • Naltrexone
  • Buprenorphine and Naloxone
Drug Type
  • Branded
  • Generics
Dosage Form
  • Extented Release
  • Immediate Release
Route of Administration
  • Others
  • Parenteral
  • Oral
Type
  • Therapy
  • Medication
Population Type
  • Teenage
  • Adults
End User
  • Others
  • Homecare
  • Speciality Centers
  • Hospitals
  • Rehabilitation Clinics
Distribution Channel
  • Others
  • Online Pharmacy
  • Retail Pharmacy
  • Direct Tender
  • Hospital Pharmacy
Frequently Asked Questions
The Global Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Products,Drug Type,Dosage Form,Route of Administration,Type,Population Type,End User,Distribution Channel.
Global Medication Assisted Therapy (MAT) Market was valued at USD 10,559.91(Revenue in ) in 2020.
Global Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 9.14% during the forecast period of 2024 to 2032.
The estimated market value of the Global Medication Assisted Therapy (MAT) Market for final year is USD 21,603.51 ().

Global Medication Assisted Therapy (MAT) Market Company Profiling

Global Medication Assisted Therapy (MAT) Market Company Profiling
Frequently Asked Questions
The Global Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Products,Drug Type,Dosage Form,Route of Administration,Type,Population Type,End User,Distribution Channel.
Global Medication Assisted Therapy (MAT) Market was valued at USD 10,559.91(Revenue in ) in 2020.
Global Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 9.14% during the forecast period of 2024 to 2032.
The estimated market value of the Global Medication Assisted Therapy (MAT) Market for final year is USD 21,603.51 ().

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.